Vaccines Against Anthrax – Selected Research

1 Aggarwal S., Somani V.K., Gupta S., Garg R., Bhatnagar R.: Development of novel multiepitope chimeric vaccine against anthrax. Med. Microbiol. Immunol. 208, 185–195 (2019) AggarwalS. SomaniV.K. GuptaS. GargR. BhatnagarR. Development of novel multiepitope chimeric vaccine against anthrax Med. Microbiol. Immunol. 208 185 195 2019 10.1007/s00430-019-00577-x30671633 Search in Google Scholar

2 Altboum Z., Gozes Y., Barnea A., Pass A., White M. Kobiler D.: Postexposure prophylaxis against anthrax: Evaluation of various treatment regimens in intranasally infected guinea pigs. Infect. Immun. 70, 6231–6241 (2002) AltboumZ. GozesY. BarneaA. PassA. WhiteM. KobilerD. Postexposure prophylaxis against anthrax: Evaluation of various treatment regimens in intranasally infected guinea pigs Infect. Immun. 70 6231 6241 2002 10.1128/IAI.70.11.6231-6241.200213032612379702 Search in Google Scholar

3 Bernstein D.I., Jackson L., Patel S.M.: Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults. Vaccine, 32, 6284–6293 (2014) BernsteinD.I. JacksonL. PatelS.M. Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults Vaccine 32 6284 6293 2014 10.1016/j.vaccine.2014.08.076425029325239484 Search in Google Scholar

4 Brossier F., Lévy. M., Landier A., Lafaye P., Mock M.: Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. Infect. Immun. 72, 6313–6317 (2004) BrossierF. Lévy.M. LandierA. LafayeP. MockM. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies Infect. Immun. 72 6313 6317 2004 10.1128/IAI.72.11.6313-6317.200452300215501759 Search in Google Scholar

5 Chabot D.J., Joyce J., Caulfield M., Cook J., Hepler R., Wang S., Vietri N.J., Ruthel G., Shoop W., Pitt L.: Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys. Vaccine, 30, 846–852 (2012) ChabotD.J. JoyceJ. CaulfieldM. CookJ. HeplerR. WangS. VietriN.J. RuthelG. ShoopW. PittL. Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys Vaccine 30 846 852 2012 10.1016/j.vaccine.2011.12.01022172509 Search in Google Scholar

6 Chabot D.J., Ribot W.J., Joyce J., Cook J., Helper R., Nahas D., Chua J., Friedlander A.M.: Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine. Vaccine, 34, 4012–4016 (2016) ChabotD.J. RibotW.J. JoyceJ. CookJ. HelperR. NahasD. ChuaJ. FriedlanderA.M. Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine Vaccine 34 4012 4016 2016 10.1016/j.vaccine.2016.06.03127329184 Search in Google Scholar

7 Chomiczewski K.: Szczepionki przeciwko wąglikowi. Wakcynologia, Bielsko-Biała: 394–397 (2005) ChomiczewskiK. Szczepionki przeciwko wąglikowi Wakcynologia Bielsko-Biała 394 397 2005 Search in Google Scholar

8 Doganay M., Demiraslan H.: Human anthrax as a re-emerging disease. Recent Pat. Antiinfect. Drug Discov. 10, 10–29 (2015) DoganayM. DemiraslanH. Human anthrax as a re-emerging disease Recent Pat. Antiinfect. Drug Discov. 10 10 29 2015 10.2174/1574891X10666150408162354 Search in Google Scholar

9 Friedlnader A.M. Little S.F.: Advances in the development of next-generation anthrax vaccines. Vaccine, 27, 28–32 (2009) FriedlnaderA.M. LittleS.F. Advances in the development of next-generation anthrax vaccines Vaccine 27 28 32 2009 10.1016/j.vaccine.2009.08.10219837282 Search in Google Scholar

10 Gubbins M.J., Berry J.D., Corbett C.R., Mogridge J., Yuan X.Y., Schmidt L., Nicolas B., Kabani A., Tsang R.S.: Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of B. anthracis protective antigen. FEMS Immunol. Med. Microbiol. 47, 436–443 (2006) GubbinsM.J. BerryJ.D. CorbettC.R. MogridgeJ. YuanX.Y. SchmidtL. NicolasB. KabaniA. TsangR.S. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of B. anthracis protective antigen FEMS Immunol. Med. Microbiol. 47 436 443 2006 10.1111/j.1574-695X.2006.00114.x711035016872381 Search in Google Scholar

11 Hanna P.: How anthrax kills. Science, 280 (5370):1671, 1673–1674 (1998) HannaP. How anthrax kills Science 280 (5370): 1671 1673 1674 1998 10.1126/science.280.5370.1671c9660700 Search in Google Scholar

12 Hicks C.W., Sweeney D.A., Cui X., Li Y., Eichacker P.Q.: An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med. 38, 1092–1104 (2012) HicksC.W. SweeneyD.A. CuiX. LiY. EichackerP.Q. An overview of anthrax infection including the recently identified form of disease in injection drug users Intensive Care Med. 38 1092 1104 2012 10.1007/s00134-012-2541-0352329922527064 Search in Google Scholar

13 Inglesby T.V., Tonat K. et al.: Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA, 287, 2236–2252 (2002) InglesbyT.V. TonatK. Anthrax as a biological weapon, 2002: updated recommendations for management JAMA 287 2236 2252 2002 10.1001/jama.287.17.223611980524 Search in Google Scholar

14 Ivins B.E., Fellows P.F., Pitt M.L.M., Estep J.E., Welkos S.L., Worsham P.L. Friedlander A.M.:. Efficacy of standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med. Bull. 87, 125–126 (1996) IvinsB.E. FellowsP.F. PittM.L.M. EstepJ.E. WelkosS.L. WorshamP.L. FriedlanderA.M. Efficacy of standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys Salisbury Med. Bull. 87 125 126 1996 Search in Google Scholar

15 Ivins B.E., Welkos S.L.: Recent advances in the development of an improved, human anthrax vaccine. Eur. J. Epidemiol. 4, 12–19 (1988) IvinsB.E. WelkosS.L. Recent advances in the development of an improved, human anthrax vaccine Eur. J. Epidemiol. 4 12 19 1988 10.1007/BF001526863128450 Search in Google Scholar

16 Leppla S.H.: The anthrax toxin complex. In: Alouf J., Freer J.H., (eds). Sourcebook of bacterial protein toxins. London Academic Press. 277–302 (1991) LepplaS.H. The anthrax toxin complex In: AloufJ. FreerJ.H. (eds). Sourcebook of bacterial protein toxins London Academic Press 277 302 1991 Search in Google Scholar

17 Liu S., Moayeri M., Leppla S.H.: Anthrax lethal and edema toxins in anthrax pathogenesis. Trends Microbiol. 22, 317–325 (2014) LiuS. MoayeriM. LepplaS.H. Anthrax lethal and edema toxins in anthrax pathogenesis Trends Microbiol. 22 317 325 2014 10.1016/j.tim.2014.02.012404183424684968 Search in Google Scholar

18 Liu X., Wang H. et al.: Genome sequence of Bacillus anthracis attenuated vaccine strain A16R used for human in China. J. Biotechnol. 210, 15–16 (2015) LiuX. WangH. Genome sequence of Bacillus anthracis attenuated vaccine strain A16R used for human in China J. Biotechnol. 210 15 16 2015 10.1016/j.jbiotec.2015.06.40826116813 Search in Google Scholar

19 Liu X., Wang D., Ren J., Tong Ch., Feng E., Wang X., Zhu L., Wang H.: Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R. PLoS One. 8, e57959. DOI:10.1371/journal.pone.0057959. (2013). LiuX. WangD. RenJ. TongCh. FengE. WangX. ZhuL. WangH. Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R PLoS One. 8 e57959 10.1371/journal.pone.0057959 2013 359633823516421 Open DOISearch in Google Scholar

20 Ma Y., Yu Y.Z., Yu-Feng Z., Qing X., Zhi-Wei S.: In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli. Hum. Vaccine Immunother. 9, 2371–2377 (2013) MaY. YuY.Z. Yu-FengZ. QingX. Zhi-WeiS. In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli Hum. Vaccine Immunother. 9 2371 2377 2013 10.4161/hv.25748398184623880942 Search in Google Scholar

21 Manzulli V., Galante D. et al.: Evaluation of in vitro antimicrobial susceptibility of Bacillus anthracis strains isolated during anthrax outbreaks in Italy from 1984 to 2017. J. Vet. Sci. 20, 58–62 (2019) ManzulliV. GalanteD. Evaluation of in vitro antimicrobial susceptibility of Bacillus anthracis strains isolated during anthrax outbreaks in Italy from 1984 to 2017 J. Vet. Sci. 20 58 62 2019 10.4142/jvs.2019.20.1.58635176130541185 Search in Google Scholar

22 McComb R.C., Martchenko M.: Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen – The first step toward a rationally designed anthrax vaccine. Vaccine, 34, 13–19 (2016) McCombR.C. MartchenkoM. Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen – The first step toward a rationally designed anthrax vaccine Vaccine 34 13 19 2016 10.1016/j.vaccine.2015.11.02526611201 Search in Google Scholar

23 Moayeri M., Leppla S.H., Vrentas C., Pomeranstev A.P., Liu S.: Anthrax pathogenesis. Annu. Rev. Microbiol. 69, 185–208 (2015) MoayeriM. LepplaS.H. VrentasC. PomeranstevA.P. LiuS. Anthrax pathogenesis Annu. Rev. Microbiol. 69 185 208 2015 10.1146/annurev-micro-091014-10452326195305 Search in Google Scholar

24 Mourez M., Kane R.S., Mogridge J., Metallo S., Deschatelets P., Sellman B.R., Whitesides G. M., Collier R.J.: Designing a polyvalent inhibitor of anthrax toxin, Nat. Biotechnol. 19, 985–961 (2001) MourezM. KaneR.S. MogridgeJ. MetalloS. DeschateletsP. SellmanB.R. WhitesidesG.M. CollierR.J. Designing a polyvalent inhibitor of anthrax toxin Nat. Biotechnol. 19 985 961 2001 10.1038/nbt1001-958 Search in Google Scholar

25 Ndumnego O.C., Köhler S.M., Crafford J., van Heerden H., Beyer W.: Comparative analysis of the immunogenic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in ruminant model. Vet. Immunol. Immunopathol. 178, 14–21(2016) NdumnegoO.C. KöhlerS.M. CraffordJ. van HeerdenH. BeyerW. Comparative analysis of the immunogenic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in ruminant model Vet. Immunol. Immunopathol. 178 14 21 2016 10.1016/j.vetimm.2016.06.005 Search in Google Scholar

26 Ndumnego O.C., Köehler S.M., Crafford J.E., Beyer W., van Heerden H.: Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model. Sci. Rep. 8:16937. DOI: 10.1038/s41598-018-35382-8 (2018) NdumnegoO.C. KöehlerS.M. CraffordJ.E. BeyerW. van HeerdenH. Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model Sci. Rep. 8 16937 10.1038/s41598-018-35382-8 2018 Open DOISearch in Google Scholar

27 Powell A.G., Crozier J.E., Hodgson H., Galloway D.J., A case of septicemic anthrax in an intravenous drug user. BMC Infect Dis. 11, 21 (2011) PowellA.G. CrozierJ.E. HodgsonH. GallowayD.J. A case of septicemic anthrax in an intravenous drug user BMC Infect Dis. 11 21 2011 10.1186/1471-2334-11-21 Search in Google Scholar

28 Quinn C.P., Marano N. et al.: A three – dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques. Clin. Vaccine Immunol. 19, 1730–1745 (2012) QuinnC.P. MaranoN. A three – dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques Clin. Vaccine Immunol. 19 1730 1745 2012 10.1128/CVI.00324-12 Search in Google Scholar

29 Sivko G.S., Stark G.V., Tordoff K.P., Taylor K.L., Glaze E., Van Raden M., Schiffer J.M., Hewitt J.A., Quinn C.P., Nuzum E.O.: Evaluation of early immune response-survival relationship in cynomolgus macaques after anthrax vaccine adsorbed vaccination and Bacillus anthracis spore challenge. Vaccine, 34, 6518–6528 (2016) SivkoG.S. StarkG.V. TordoffK.P. TaylorK.L. GlazeE. Van RadenM. SchifferJ.M. HewittJ.A. QuinnC.P. NuzumE.O. Evaluation of early immune response-survival relationship in cynomolgus macaques after anthrax vaccine adsorbed vaccination and Bacillus anthracis spore challenge Vaccine 34 6518 6528 2016 10.1016/j.vaccine.2016.04.048 Search in Google Scholar

30 Tao P., Mahalingam M., Zhu J., Moayeri M., Kirtley M.L.: A bivalent anthrax-plague vaccine that can protect against two tier-1 bioterror pathogens, Bacillus anthracis and Yersinia pestis. Front. Immunol. 8, 687 (2017) TaoP. MahalingamM. ZhuJ. MoayeriM. KirtleyM.L. A bivalent anthrax-plague vaccine that can protect against two tier-1 bioterror pathogens, Bacillus anthracis and Yersinia pestis Front. Immunol. 8 687 2017 10.3389/fimmu.2017.00687 Search in Google Scholar

31 Tao P., Mahalingam M., Zhu J., Moayeri M., Sha J., Lawrence W.S., Leppla S.H., Chopra A.K., Rao V.B.:. A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague. mBio, 9, e01926-18 (2018) TaoP. MahalingamM. ZhuJ. MoayeriM. ShaJ. LawrenceW.S. LepplaS.H. ChopraA.K. RaoV.B. A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague mBio 9 e01926-18 2018 10.1128/mBio.01926-18 Search in Google Scholar

32 Turnbull P.C.B.: Anthrax vaccines: past, present and future. Vaccine, 9, 533–539 (1991) TurnbullP.C.B. Anthrax vaccines: past, present and future Vaccine 9 533 539 1991 10.1016/0264-410X(91)90237-Z Search in Google Scholar

33 US Army Medical Research Institute of Infectious Diseases: Anthrax capsule vaccine completely protects monkeys from lethal inhalational anthrax. 27.07.2016, http://www.sciencedaily.com/releases/2016/06/160627125302.htm (5.12.2021) US Army Medical Research Institute of Infectious Diseases Anthrax capsule vaccine completely protects monkeys from lethal inhalational anthrax. 27.07.2016 http://www.sciencedaily.com/releases/2016/06/160627125302.htm (5.12.2021) Search in Google Scholar

34 Varshney A., Puranik N., Kumar M., Goel A.K.: The humoral immune response to various domains of protective antigen of Bacillus anthracis in cutaneous anthrax cases in India. Defence Sci. J. 66, 645–650 (2016) VarshneyA. PuranikN. KumarM. GoelA.K. The humoral immune response to various domains of protective antigen of Bacillus anthracis in cutaneous anthrax cases in India Defence Sci. J. 66 645 650 2016 10.14429/dsj.66.10805 Search in Google Scholar

35 Veitch J., Kansara A., Bailey D., Kustos I.: Severe systemic Bacillus anthracis infection in an intravenous drug user. BMJ Case Rep. 13, doi:10.1136/bcr-2013-201921 (2014) VeitchJ. KansaraA. BaileyD. KustosI. Severe systemic Bacillus anthracis infection in an intravenous drug user BMJ Case Rep. 13 10.1136/bcr-2013-201921 2014 392644824526196 Open DOISearch in Google Scholar

36 Williamson E.D., Dyson E.H.: Anthrax prophylaxis: recent advances and future directions. Front. Microbial. 6, 1009 (2015) WilliamsonE.D. DysonE.H. Anthrax prophylaxis: recent advances and future directions Front. Microbial. 6 1009 2015 10.3389/fmicb.2015.01009458522426441934 Search in Google Scholar

37 Woo S.J., Kang S.S., Park S.M., Yang J.S., Song M.K., Yan C.H., Han S.H.: Intranasal immunization with protective antigen of Bacillus anthracis induces a long-term immunological memory response. Mol. Immunol. 67, 492–500 (2015) WooS.J. KangS.S. ParkS.M. YangJ.S. SongM.K. YanC.H. HanS.H. Intranasal immunization with protective antigen of Bacillus anthracis induces a long-term immunological memory response Mol. Immunol. 67 492 500 2015 10.1016/j.molimm.2015.08.00226278659 Search in Google Scholar

38 Wright J.G, Quinn C.P. et al.: Effect of reduced dose schedules and intramuscular injection of anthrax adsorbed on immunological response and safety profile: A randomized trial. Vaccine, 32, 1019–1028 (2014) WrightJ.G QuinnC.P. Effect of reduced dose schedules and intramuscular injection of anthrax adsorbed on immunological response and safety profile: A randomized trial Vaccine 32 1019 1028 2014 10.1016/j.vaccine.2013.10.039906739024373307 Search in Google Scholar

39 Żakowska D., Bartoszcze M., Kocik J. Nowe możliwości hamowania infekcji B. anthracis. Medycyna Wet. 67, 665–668 (2011) ŻakowskaD. BartoszczeM. KocikJ. Nowe możliwości hamowania infekcji B. anthracis Medycyna Wet. 67 665 668 2011 Search in Google Scholar

40 Żakowska D., Kocik J., Bartoszcze M.: Wybrane kierunki badań nad szczepionkami przeciwko wąglikowi. Przegl. Epidemiol. 63, 505–512 (2009) ŻakowskaD. KocikJ. BartoszczeM. Wybrane kierunki badań nad szczepionkami przeciwko wąglikowi Przegl. Epidemiol. 63 505 512 2009 Search in Google Scholar